litlas
Log inCreate account

Michael F. Press

Active 1977–2025

128
Papers
45,516
Citations
89
h-index
126
i10-index

Citations

Citations per year for Michael F. Press1974: 1 citations1976: 1 citations1978: 1 citations1979: 1 citations1980: 1 citations1982: 1 citations1985: 4 citations1986: 12 citations1987: 15 citations1988: 24 citations1989: 18 citations1990: 51 citations1991: 64 citations1992: 76 citations1993: 60 citations1994: 74 citations1995: 82 citations1996: 62 citations1997: 100 citations1998: 95 citations1999: 132 citations2000: 203 citations2001: 220 citations2002: 216 citations2003: 217 citations2004: 236 citations2005: 257 citations2006: 251 citations2007: 307 citations2008: 345 citations2009: 382 citations2010: 405 citations2011: 367 citations2012: 426 citations2013: 425 citations2014: 389 citations2015: 352 citations2016: 327 citations2017: 331 citations2018: 297 citations2019: 913 citations2020: 907 citations2021: 948 citations2022: 737 citations2023: 609 citations2024: 844 citations2025: 407 citations2026: 18 citations1975: no citations, so this year is not shown1977: no citations, so this year is not shown1981: no citations, so this year is not shown1983–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,858 citing papers, 28.9% of this breakdownChina: 1,249 citing papers, 7.4% of this breakdownUnited Kingdom: 1,130 citing papers, 6.7% of this breakdownGermany: 799 citing papers, 4.7% of this breakdownItaly: 791 citing papers, 4.7% of this breakdownCanada: 667 citing papers, 4% of this breakdownFrance: 566 citing papers, 3.4% of this breakdownSpain: 543 citing papers, 3.2% of this breakdownJapan: 487 citing papers, 2.9% of this breakdownAustralia: 402 citing papers, 2.4% of this breakdownSouth Korea: 398 citing papers, 2.4% of this breakdownSwitzerland: 379 citing papers, 2.3% of this breakdown
0%28.9%Other 27%

Institutions

Fields

  • Medicine57.3%
  • Biochemistry, Genetics and Molecular Biology33.2%
  • Immunology and Microbiology2.8%
  • Computer Science2.7%
  • Neuroscience0.8%
  • Materials Science0.7%
  • Other2.5%

Topics

  • HER2/EGFR in Cancer Research11%
  • Breast Cancer Treatment Studies6.3%
  • Monoclonal and Polyclonal Antibodies Research5%
  • Cancer Genomics and Diagnostics3.2%
  • Advanced Breast Cancer Therapies2.8%
  • Cancer Cells and Metastasis2%
  • Other69.7%

Coauthors

All papers

Open in search
  1. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    Authors: Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison, Brittany Harvey, Pamela B. Mangu, John M.S. Bartlett, Michael Bilous, Ian O. Ellis, Patrick L. Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Lisa M. McShane, Mitch Dowsett - Archives of Pathology & Laboratory Medicine 2018 cited by 2,454

  2. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    Authors: P. Tarantino, Giulia Viale, Michael F. Press, Xin Hu, Frédérique Penault‐Llorca, A. Bardia, Anna Batistatou, H.J. Burstein, L.A. Carey, Javier Cortés, C. Denkert, V. Diéras, William Jacot, A. Koutras, Alizée Lebeau, S. Loibl, Shanu Modi, M.F. Mosele, Elena Provenzano, Giancarlo Pruneri, Jorge S. Reis‐Filho, Federico Rojo, Roberto Salgado, P. Schmid, Stuart J. Schnitt, S.M. Tolaney, Dario Trapani, A. Vincent-Salomon, A.C. Wolff, George Pentheroudakis, Fabrice André, G. Curigliano - Annals of Oncology 2023 cited by 299

  3. Adjuvant Trastuzumab in HER2-Positive Breast Cancer

    Authors: Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown - New England Journal of Medicine 2011 cited by 2,775

  4. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

    Authors: Dennis J. Slamon, William Godolphin, Lovell A. Jones, John A. Holt, Steven Wong, Duane E. Keith, Wendy J. Levin, Susan G. Stuart, Judy Udove, Axel Ullrich, Michael F. Press - Science 1989 cited by 6,863

  5. Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains

    Authors: Nikhil Naik, Ali Madani, Andre Esteva, Nitish Shirish Keskar, Michael F. Press, Daniel Ruderman, David B. Agus, Richard Socher - Nature Communications 2020 cited by 249

  6. A Big Bang model of human colorectal tumor growth

    Authors: Andrea Sottoriva, Haeyoun Kang, Zhicheng Ma, Trevor A. Graham, Matthew P. Salomon, Junsong Zhao, Paul Marjoram, Kimberly D. Siegmund, Michael F. Press, Darryl Shibata, Christina Curtis - Nature Genetics 2015 cited by 1,058

  7. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    Authors: Rosie Bradley, Jeremy Braybrooke, Richard J. Gray, Robert K. Hills, Zulian Liu, Richárd Pető, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, Stewart Anderson, Richard D. Gelber, Luca Gianni, William Jacot, Heikki Joensuu, Alvaro Moreno‐Aspitia, Martine Piccart, Michael F. Press, Edward H. Romond, Dennis J. Slamon, Vera J. Suman, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles E. Geyer, M. Spielmann, Pinuccia Valagussa, Kathy S. Albain, Stewart Anderson, R. Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Bidwell Goetz, Pam Goodwin, Pat Halpin-Murphy, Daniel Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori J. Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Tanja Španić, Joseph A. Sparano, Guenther G. Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Timothy J. Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I. Pritchard and 1 more - The Lancet Oncology 2021 cited by 348

  8. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    Authors: Jeremy Braybrooke, Rosie Bradley, Richard Gray, Robert K. Hills, Hongchao Pan, Richárd Pető, David Dodwell, Paul McGale, Carolyn Taylor, Tomohiko Aihara, Stewart Anderson, Joanne L. Blum, Fátima Cardoso, Xiaosong Chen, John Crown, Bent Ejlertsen, Thomas W. P. Friedl, Nadia Harbeck, Wolfgang Janni, Maj‐Britt Jensen, E. Mamounas, Kazutaka Narui, Ulrike Nitz, Larry Norton, Joyce O’Shaughnessy, Martine Piccart, Nicholas J. Robert, Zhi‐Ming Shao, Dennis Slamon, Joseph A. Sparano, Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren and 136 more - The Lancet 2023 cited by 189

  9. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

    Authors: Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, Mitch Dowsett, Lisa M. McShane, Kimberly H. Allison, D. Craig Allred, John M.S. Bartlett, Michael Bilous, Patrick L. Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Pamela B. Mangu, Soonmyung Paik, Edith A. Perez, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Daniel F. Hayes - Archives of Pathology & Laboratory Medicine 2013 cited by 4,061

  10. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial

    Authors: J. Randolph Hecht, Yung‐Jue Bang, Shukui Qin, Hyun Cheol Chung, Jianming Xu, Joon Oh Park, Krzysztof Jeziorski, Yaroslav Shparyk, Paulo M. Hoff, Alberto Sobrero, Pamela Salman, Jin Li, Светлана Проценко, Zev A. Wainberg, Marc Buyse, Karen Afenjar, Vincent Houé, Agathe Garcia, Tomomi Kaneko, Yingjie Huang, S. Khan‐Wasti, Sergio Santillana, Michael F. Press, Dennis J. Slamon - Journal of Clinical Oncology 2015 cited by 621

  11. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

    Authors: Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz, Karen L. Hagerty, D. Craig Allred, Richard J. Côté, Mitch Dowsett, Patrick L. Fitzgibbons, Wedad Hanna, Amy S. Langer, Lisa M. McShane, Soonmyung Paik, Mark D. Pegram, Edith A. Perez, Michael F. Press, Anthony Rhodes, Catharine M. Sturgeon, Sheila E. Taube, Raymond Tubbs, Gail H. Vance, Marc J. van de Vijver, Thomas M. Wheeler, Daniel F. Hayes - Archives of Pathology & Laboratory Medicine 2006 cited by 4,475

  12. Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer

    Authors: Sara A. Hurvitz, Miguel Martín, Michael F. Press, David Chan, María Fernandez-Abad, Edgar Petru, Regan Rostorfer, Valentina Guarneri, Chiun‐Sheng Huang, Susana Barriga, Sameera R. Wijayawardana, Manisha Brahmachary, Philip J. Ebert, Anwar Hossain, Jiangang Liu, Adam Abel, Amit Aggarwal, Valerie M. Jansen, Dennis J. Slamon - Clinical Cancer Research 2019 cited by 220

  13. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

    Authors: Charles L. Vogel, Melody Cobleigh, Debu Tripathy, John Gutheil, Lyndsay N. Harris, Louis Fehrenbacher, Dennis J. Slamon, Maureen Murphy, William Novotny, Michael Burchmore, Steven Shak, Stanford J. Stewart, Michael F. Press - Journal of Clinical Oncology 2002 cited by 1,859

  14. Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers

    Authors: Rémi Klotz, Amal Thomas, Teng Teng, Sung Min Han, Oihana Iriondo, Lin Li, Sara Restrepo-Vassalli, Alan Wang, Negeen Izadian, Matthew MacKay, Byoung-San Moon, Kevin J. Liu, Sathish Kumar Ganesan, Grace Lee, Diane S. Kang, Charlotte S. Walmsley, Christopher J. Pinto, Michael F. Press, Wange Lu, Janice Lu, Dejan Juric, Aditya Bardia, James Hicks, Bodour Salhia, Frank J. Attenello, Andrew D. Smith, Min Yu - Cancer Discovery 2019 cited by 142

  15. Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

    Authors: Stephen Johnston, John Pippen, Xavier Pivot, Mikhail Lichinitser, Saeed Sadeghi, Véronique Dièras, Henry Gómez, Gilles Romieu, Alexey Manikhas, M. John Kennedy, Michael F. Press, J. Maltzman, Allison Florance, Lisa O’Rourke, Cristina Oliva, Steven Stein, Mark D. Pegram - Journal of Clinical Oncology 2009 cited by 1,024

  16. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE

    Authors: Stephen Johnston, Roberto Hegg, Seock‐Ah Im, In Hae Park, Olga Burdaeva, G. Kurteva, Michael F. Press, Sergei Tjulandin, Hiroji Iwata, Sérgio D. Simon, Sarah Kenny, Séverine Sarp, Miguel Izquierdo, Lisa S. Williams, William J. Gradishar - Journal of Clinical Oncology 2020 cited by 126

  17. Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE)

    Authors: Sanne Lysbet de Haas, Dennis J. Slamon, Miguel Martín, Michael F. Press, Gail D. Lewis Phillips, Chiara Lambertini, Aleix Prat, Vanesa López-Valverde, Thomas Boulet, Sara A. Hurvitz - Breast Cancer Research 2023 cited by 43

  18. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: ALTERNATIVE

    Authors: Stephen Johnston, Roberto Hegg, Seock‐Ah Im, In Hae Park, Olga Burdaeva, G. Kurteva, Michael F. Press, Sergei Tjulandin, Hiroji Iwata, Sérgio D. Simon, Sarah Kenny, Séverine Sarp, Miguel Izquierdo, Lisa S. Williams, William J. Gradishar - Journal of Clinical Oncology 2017 cited by 166

  19. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

    Authors: Michael F. Press, Carlos Cordon‐Cardo, Dennis J. Slamon - 1990 cited by 648

  20. Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors

    Authors: Martina S.J. McDermott, Neil A. O’Brien, Benjamin Hoffstrom, KeWei Gong, Ming Lu, Jun Zhang, Tong Luo, Min Liang, Weiping Jia, Jenny J. Hong, Kevin Chau, Simon Davenport, Bin Xie, Michael F. Press, Richard Panayiotou, Abram Handly‐Santana, Joan S. Brugge, Leonard Presta, John A. Glaspy, Dennis J. Slamon - Clinical Cancer Research 2023 cited by 53

  21. A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System

    Authors: Evan N. Cohen, Gitanjali Jayachandran, Richard G. Moore, Massimo Cristofanilli, Julie E. Lang, Joseph D. Khoury, Michael F. Press, Kyu Kwang Kim, Negar Khazan, Qiang Zhang, Youbin Zhang, Pushpinder Kaur, Roberta Guzman, Michael Craig Miller, James M. Reuben, Naoto T. Ueno - Cancers 2022 cited by 58

  22. Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry

    Authors: Zhaohui Du, Guimin Gao, Babatunde Adedokun, Thomas U. Ahearn, Kathryn L. Lunetta, Gary Zirpoli, Melissa A. Troester, Edward Ruiz-Narváez, Stephen A. Haddad, Parichoy PalChoudhury, Jonine D. Figueroa, Esther M. John, Leslie Bernstein, Wei Zheng, Jennifer J. Hu, Regina G. Ziegler, Sarah J. Nyante, Elisa V. Bandera, Sue A. Ingles, Nicholas Mancuso, Michael F. Press, Sandra L. Deming, Jorge L. Rodriguez‐Gil, Song Yao, Temidayo O. Ogundiran, Oladosu Ojengbe, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, Douglas F. Easton, Kyriaki Michailidou, Paul D.P. Pharoah, Dale P. Sandler, Jack A. Taylor, Qin Wang, Clarice R. Weinberg, Cari M. Kitahara, William J. Blot, Katherine L. Nathanson, Anselm Hennis, Barbara Nemesure, Stefan Ambs, Lara Sucheston‐Campbell, Jeannette T. Bensen, Stephen J. Chanock, Andrew F. Olshan, Christine B. Ambrosone, Olufunmilayo I. Olopade, Joel Yarney, Baffour Awuah, Beatrice Wiafe‐Addai, David V. Conti, the GBHS Study Team, Julie R. Palmer, Montserrat García‐Closas, Dezheng Huo, Christopher A. Haiman - JNCI Journal of the National Cancer Institute 2021 cited by 76

  23. Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

    Authors: Aditya Bardia, Sara A. Hurvitz, Michael F. Press, Lisa S. Wang, Nicholas P. McAndrew, David W. Chan, Vu Phan, Deborah Villa, Merry Tetef, Erin Chamberlain, Nihal Abdulla, Thomas J. Lomis, Laura M. Spring, Steven Applebaum, Shaker R. Dakhil, Brian DiCarlo, David D. Kim, Evangelia Kirimis, William Lawler, Aashini K. Master, Kelly McCann, Edwin Hayashi, Christine Kivork, James Chauv - Cancer Research 2023 cited by 31

  24. Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction

    Authors: Guochong Jia, Jie Ping, Xingyi Guo, Yaohua Yang, Ran Tao, Bingshan Li, Stefan Ambs, Mollie E. Barnard, Yu Chen, Montserrat García‐Closas, Jian Gu, Jennifer J. Hu, Dezheng Huo, Esther M. John, Christopher I. Li, James Li, Katherine L. Nathanson, Barbara Nemesure, Olufunmilayo I. Olopade, Tuya Pal, Michael F. Press, Maureen Sanderson, Dale P. Sandler, Xiao‐Ou Shu, Melissa A. Troester, Song Yao, Prisca Olabisi Adejumo, Thomas U. Ahearn, Abenaa M. Brewster, Anselm Hennis, Timothy Makumbi, Paul Ndom, Katie M. O’Brien, Andrew F. Olshan, Mojisola Oluwasanu, Sonya Reid, Eboneé N. Butler, Maosheng Huang, Atara Ntekim, Huijun Qian, Haoyu Zhang, Christine B. Ambrosone, Qiuyin Cai, Jirong Long, Julie R. Palmer, Christopher A. Haiman, Wei Zheng - Nature Genetics 2024 cited by 56